epiberberine has been researched along with salvianolic acid B in 2 studies
| Studies (epiberberine) | Trials (epiberberine) | Recent Studies (post-2010) (epiberberine) | Studies (salvianolic acid B) | Trials (salvianolic acid B) | Recent Studies (post-2010) (salvianolic acid B) |
|---|---|---|---|---|---|
| 49 | 0 | 37 | 624 | 2 | 432 |
| Protein | Taxonomy | epiberberine (IC50) | salvianolic acid B (IC50) |
|---|---|---|---|
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 0.11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, DJ; Li, J; Yu, B | 1 |
| Agboyibor, C; Bi, Y; Dong, J; Gong, H; Kang, L; Li, D; Li, J; Liu, H; Ma, X; Pervaiz, W; Tayyab, B; Zhang, H | 1 |
2 review(s) available for epiberberine and salvianolic acid B
| Article | Year |
|---|---|
Annual review of LSD1/KDM1A inhibitors in 2020.
Topics: Antineoplastic Agents, Phytogenic; Enzyme Inhibitors; Histone Demethylases; Humans; Molecular Structure; Neoplasms | 2021 |
A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors.
Topics: Carcinogenesis; Histone Demethylases; Humans; Neoplasms | 2022 |